Rabbit hemorrhagic disease virus (RHDV) has two structural proteins: the major capsid protein VP60 and the minor capsid protein VP2. VP2 is speculated to play an important role in the virus life cycle. To investigate the effect of VP2 on VP60 expression, three types of experiment (baculovirus-insect cell system, mammalian-luciferase assay system and in vitro coupled transcription/translation system) were used to express VP60 alone or co-expressed with VP2. Both forms of VP60 were able to form virus-like particles in insect cells. Western blot analysis and dual-luciferase assays demonstrated that the presence of VP2 results in downregulation of the expression of VP60 in vivo. Real-time RT-PCR of mRNA levels showed that downregulation of VP60 occurs at the transcriptional level. The ability of the viral minor structural protein VP2 to regulate capsid protein levels may contribute to effective virus infection.
Rabbit hemorrhagic disease virus (RHDV; genus Lagovirus, family Caliciviridae) is the causative agent of a highly contagious disease of wild and domestic rabbits that has been known in China for more than 25 years (Liu et al., 1984) . RHDV is a non-enveloped RNA virus with particles 30-40 nm in diameter. Its genome is a 7.5 kb, positive, single-stranded RNA with two open reading frames (ORFs) and a poly(A) tail. ORF1 encodes a polyprotein of 257 kDa that is predicted to be cleaved into several mature proteins, including an NTPase, a proteinase, an RNA-dependent RNA polymerase and the virion coat protein VP60 (Meyers et al., 1991a; Martín Alonso et al., 1996; Wirblich et al., 1996) . ORF2 is much smaller (351 nt) and encodes a single polypeptide of 12.7 kDa (VP2, the minor structural protein). It occurs in the 39 region of the genome, overlapping the 39 end of the capsid gene by 17 nt (Meyers et al., 1991a) . During virus infection, a subgenomic viral RNA of 2.2 kb, collinear with the 39-terminal part of the genome, is produced. The subgenomic RNA contains the coding region of the major capsid protein VP60, and ORF2 (Meyers et al., 1991a, b; Ohlinger et al., 1990) . The translation of VP2 is initiated by a new termination-dependent reinitiating mechanism, which occurs within the coupled ORF1 stop codon-ORF2 start codon region and relies on the 39-terminal 84 nt of ORF1, but not the encoded peptide (Meyers, 2003) . The expression level of the VP2 protein is very low and has been estimated to be one-fifth of that of VP60 (Meyers, 2003) .
Conservation of ORF2 in all caliciviruses (and the homologous ORF3 of noroviruses and vesiviruses) suggests that it plays an important role in the virus life cycle. However, virus-like particles (VLPs) were produced by expressing VP60 alone in insect cells, suggesting that VP2 is dispensable for capsid formation (Laurent et al., 1994) . There are two main hypotheses about the function of VP2 at present. One is that the VP2 protein might play a role in virus-particle assembly by interacting with both VP60 and the viral RNA (or the RHDV VPg protein linked to virus RNA), thus mediating specific encapsidation of the virus genome (Sosnovtsev et al., 2005) . The other idea is that it may be a regulatory factor related to virus replication, protein expression or virus-induced cell apoptosis, etc.
As RHDV cannot be propagated well under tissue-or cellculture conditions, much research progress in caliciviruses has been made by in vitro translation or by using the baculovirus system. In 2006, we successfully constructed an infectious cDNA clone of RHDV (Liu et al., 2006) . We then showed that VP2 is not essential for the production of infectious virons of RHDV (Liu et al., 2008) , in contrast to results with the corresponding VP2 protein of feline calicivirus (FCV), a member of the genus Vesivirus (Sosnovtsev et al., 2005) . In Norwalk virus (NV), VP2 was shown to increase the expression of capsid protein VP1 and to stabilize it (Bertolotti-Ciarlet et al., 2003) and we found that the presence of RHDV VP2 can increase virus replication (Liu et al., 2008) . We now report experiments investigating the effect of RHDV VP2 on the expression of VP60 in vitro and in vivo, showing that VP2 is capable of downregulating the expression of VP60.
Recombinant plasmids were constructed to monitor the expression levels of RHDV VP60 in Spodoptera frugiperda 9 (Sf9) insect cells, in mammalian (rabbit kidney) RK13 cells and in the TNT coupled reticulocyte-lysate system (Promega). The primers used are listed in Supplementary  Table S1 (available in JGV Online).
Protein expression and VLP assembly in Sf9 insect cells were tested following infection by recombinant baculoviruses. Sf9 cells were grown and maintained in monolayer cultures at 27 u C in SF-900II (Gibco-BRL) medium supplemented with 2 % fetal bovine serum (FBS) plus penicillin (100 U ml
21
) and streptomycin (100 mg ml
). Recombinant baculovirus DNA harbouring either the RHDV VP60 or VP60VP2 gene was prepared by using the baculoviral expression vector pFastBac1 (Gibco-BRL). The coding regions of RHDV VP60 or VP60VP2 were amplified from the recombinant plasmid pBL-RHDV containing the full-length genome of RHDV strain CHA (Liu et al., 2006) , using primer VP60+(SalI) together with either VP602(HindIII) or VP60VP22(HindIII). The fragments obtained were digested with SalI and HindIII and inserted into the corresponding region of pFastBac1. The resultant constructs pFastVP60 and pFastVP60VP2 were verified by enzyme digestion and DNA sequencing. The recombinant baculoviruses (named rBv-VP60 and rBv-VP60VP2) were generated by using the Bac-to-Bac baculovirus expression system (Gibco-BRL) according to the manufacturer's protocol. Protein expression was examined by using an indirect immunofluorescence assay (IFA). Cells were fixed in cold methanol : acetone (1 : 1, v/ v) at 220 u C for 30 min, washed with PBS and stained with a mouse polyclonal antibody specific for VP60 or VP2 (1 : 100 dilution in PBS) generated in our laboratory, followed by goat anti-mouse IgG conjugated to fluorescein isothiocyanate (1 : 100 dilution with 0.1 % Evans blue solution; Beijing zsbio). Finally, the samples were observed under a fluorescence microscope.
The VP60 protein was expressed well in both types of recombinant virus-infected Sf9 cells ( Supplementary Fig.  S1a , c), whereas VP2 was only expressed in cells infected with rBv-VP60VP2 ( Supplementary Fig. S1d ). When infected-cell lysates were analysed by SDS-PAGE and Western blot analysis, a major protein band (about 60 kDa) that reacted with anti-VP60 antiserum was detected ( Supplementary Fig. S2a ). Cells infected with rBv-VP60VP2 were recognized by the anti-VP2 antiserum, whereas cells infected with rBv-VP60 were not ( Supplementary Fig. S2b ). Electron microscopy of negatively stained preparations showed that VLPs were formed in both types of virus-infected cells and that the VLPs from the two samples had a very similar conformation, reported to be structurally indistinguishable from the RHDV virion ( Supplementary Fig. S3 ) (Laurent et al., 1994) .
Then, Sf9 cells were seeded at 9610 5 cells per well in a sixwell dish and, 24 h later, infected with rBv-VP60 or rBv-VP60VP2 at the same titre (at an m.o.i. of about 0.5). Cells and culture medium were collected 12-60 h post-infection (p.i.) and subjected to Western blot analysis or a real-time RT-PCR assay for detecting the protein and mRNA levels of VP60. Western blot analysis indicated that the expression levels of VP60 in cell lysates infected with rBv-VP60 were about 3-and 5-fold higher, respectively, than those from rBv-VP60VP2 treatment at 48 and 60 h p.i. (Fig. 1a) . In addition to the expected 60 kDa band, smaller protein bands of about 45 and 34 kDa were seen; these may be degradation or cleavage products of VP60. Expression levels of VP60 in supernatants (Fig. 1b) were also higher for rBv-VP60-treated cells than for rBv-VP60VP2-treated cells.
Total RNA was also isolated by using an RNA Easy mini kit (Qiagen) from parallel cell samples, and real-time RT-PCR was used to test for transcriptional levels of VP60 mRNA. An RT-PCR kit (TaKaRa) was used according to the manufacturer's instructions. Primers 59-AGGACAAAAC-GAGAATGAAGGA-39 and 59-GCTGGGCTATGGAACA-CAAAC-39 were used to amplify a 142 bp region of the VP60 gene, whilst the primer pair 59-CTCAACCCCA-AGGCCAACAG-39 and 59-TCACCGGAGTCCAGCAC-GAT-39 was used to amplify b-actin as a control to normalize input amounts of RNA and the levels of VP60 expression between different cell samples. VP60 mRNA levels were lower in cells infected with rBv-VP60VP2 than in those infected with rBv-VP60 (Fig. 2a) . The data from the insect cells thus show that both VP60 expression and the corresponding mRNA levels were lower in the presence of VP2.
The effect of VP2 on the expression levels of VP60 in mammalian cells was then tested by using RK13 cells transfected with recombinant plasmids containing the luciferase gene (ff-luc). The RK13 cell line was obtained from the China Center for Type Culture Collection and was cultured in minimum essential medium (Gibco-BRL) supplemented with 10 % FBS, 100 U penicillin ml 21 and 100 mg streptomycin ml
. ff-luc and RHDV VP60 or VP60VP2 were cloned sequentially into the pcDNA3.1(+) vector and a flexible linker (GSGGSG) was inserted between the two proteins to allow efficient expression and folding of both proteins. ff-luc was amplified from the pGL3-basic vector (Clontech) by using the primer pair Luc+(KpnI) and Luc2(EcoRV). The ff-luc gene was digested with KpnI and EcoRV and cloned into the corresponding region of pcDNA3.1(+), and the plasmid obtained was named pcluc. VP60 and VP60VP2 fragments, amplified separately by using the primer pairs VP60+(EcoRV) and VP602(XhoI) or VP60+(EcoRV) and VP60VP22(XhoI), were treated with EcoRV and XhoI and inserted into the corresponding region of pcluc. The resultant plasmids were identified by enzyme digestion and sequencing and named pclucVP60 and pclucVP60VP2, respectively. Confluent monolayers of RK13 cells, seeded in a 96-well plate, were either mock-treated or transfected with 100 ng test DNA [pcDNA3.1(+), pclucVP60 or pclucVP60VP2] together with 0.5 ml Lipofectamine 2000 (Invitrogen). All samples were co-transfected with 100 ng pRL-tk (Promega), constitutively expressing Renilla luciferase (RL-luc), for internal normalization of firefly luciferase. Twenty-four hours post-transfection, ff-luc and RL-luc activities were quantified by using the DualLuciferase Reporter Assay system (Promega) in a Turner TD-20/20 luminometer (Turner Designs), following the manufacturer's instructions. Luciferase activity was calculated from the ratios of ff-luc : RL-luc of a lysate sample to control for transfection efficiency and lysate concentration. Three independent experiments were done and means and SEM were calculated.
Expression of VP60 and/or VP2 in the transfected RK13 cells was confirmed by IFA and Western blot analysis. Luciferase-activity analysis 36 h after transfection (Fig. 2b) indicated that the expression level of VP60 was about 3-fold higher in pclucVP60-transfected cells than in those transfected by pclucVP60VP2. These results are consistent with those from the baculovirus-insect cell system and confirm that VP2 not only reduces the levels of subgenomic RNA [reported by Parra et al. (1993) to be the major source of capsid protein assembled into mature virions], but also downregulates the expression of VP60 over a similar time period.
In an attempt to confirm these results further, an in vitro coupled transcription/translation was also performed by using the TNT T7 Quick Coupled Transcription/ Translation system (Promega) according to the manufacturer's instructions. VP60 and VP60VP2 were first amplified with the primer pairs VP60+(SalI) and VP602(HindIII) or VP60+(SalI) and VP60VP22 (HindIII), and were then inserted into the pBluescript SK+ vector (Stratagene), which contains a T7 promoter in the site of SalI and HindIII enzymes. The vectors obtained were named pskVP60 and pskVP60VP2, respectively. pskVP60 (0.934 mg) or pskVP60VP2 (1.0 mg; equal molar ratio to pskVP60) circular plasmid DNA template, together with 40 ml TNT Quick Master Mix, 1 ml methionine (1 mM), 1-2 ml Transcend biotin-lysyl-tRNA in a 50 ml reaction volume was incubated for 90 min at 30 u C. A positive control (luciferase control DNA provided in the kit) and a negative control (without added DNA) were also included. Reaction products (1-2 ml) were separated by SDS-PAGE, transferred to an NC membrane (Millipore) and detected by using the Transcend Colorimetric Translation detection system (Promega). The results (Fig.  3) suggest that there was no significant difference between the expression products from pskVP60 and pskVP60VP2. These results are therefore not consistent with those obtained by the other two systems, but we believe that this may be an artefact arising from the absence of some important cellular factors involved in the regulation process from the TNT Quick Master Mix. A similar conclusion was reached by Bertolotti-Ciarlet et al. (2003) in their studies of the effect of the NV VP2 protein on the expression level of VP1 in a reticulocyte-lysate system. Apoptosis of hepatocytes in rabbits caused by RHDV infection might be a determinant in the development of the pathogenesis of rabbit haemorrhagic disease (Alonso et al., 1998; Ramiro-Ibáñez et al., 1999; Jung et al., 2000) . Further studies in FCV have demonstrated that FCV replication and de novo synthesis of virus proteins are critical for the induction of apoptosis (Sosnovtsev et al., 2003) . Therefore, we speculate that those regulatory functions of the VP2 protein that increase the levels of virus replication and downregulate the expression of VP60 are related to balancing the cell apoptosis processes, and then to regulating the process of virus amplification and release from host cells.
Further experiments are needed to understand the mechanism by which VP2 regulates the expression of VP60. The results of comparative real-time RT-PCR indicated that downregulation of VP60 occurs at the transcriptional level, but we cannot exclude the possibility that VP2 also regulates VP60 protein expression at the translational, or even post-translational, level. We will therefore be investigating the half-life of VP60 (reflecting protein-turnover rate) in the presence or absence of VP2 and will also investigate the interactions between VP2, VP60, viral RNA and the host cellular factors that are involved in mRNA transcription, protein translation and protein degradation. Such studies will help us to understand the pathogenesis of RHDV and encourage the design of antiviral drugs or vaccines. 
